Medindia LOGIN REGISTER
Medindia

Aurobindo Pharma Gets US FDA Nod for Donepezil Hydrochloride Tablets

by Dr. Trupti Shirole on Jun 2 2011 3:43 PM

The US Food and Drug Administration (US FDA) has given its final approval to Aurobindo Pharma Ltd. for 5mg and 10mg Donepezil Hydrochloride tablets.

 Aurobindo Pharma Gets US FDA Nod for Donepezil Hydrochloride Tablets
The US Food and Drug Administration (US FDA) has given its final approval to Aurobindo Pharma Ltd. for 5mg and 10mg Donepezil Hydrochloride tablets.
These tablets are generically equivalent to Aricept tablets (sold by Eisai Medical Research Inc. in partnership with Pfizer) and fall under the Central Nervous System therapeutic segment that are meant for the treatment of mild, moderate and severe dementia and Alzheimer's disease.

The product had a market size of approximately USD 2.5 billion for the twelve months ended September 2010, according to IMS.


Source-Medindia


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional